Who owns LAVA THERAPEUTICS NV?
- Ticker: LVTX
- CUSIP Number: n51517105
Tip: Access positions for across all investors
Analyze quarterly positions in Lava Therapeutics Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lava Therapeutics Nv stock
Who bought or sold LAVA THERAPEUTICS NV this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Redmile Group | 2.1M | $6.9M | 0% | Mar 2024 |
|
| Bruce & Co | 772k | $2.6M | 0% | Mar 2024 |
|
| Sphera Funds Management | 368k | $1.2M | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 155k | $515k | 100% | Mar 2024 |
|
| Two Sigma Investments | 82k | $273k | 100% | Mar 2024 |
|
| Pnc Financial Services | 65k | $217k | 0% | Mar 2024 |
|
| Citadel Advisors | 53k | $178k | 148% | Mar 2024 |
|
| Millennium Management | 20k | $67k | -29% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 18k | $61k | 100% | Mar 2024 |
|
| Susquehanna International | 18k | $59k | 4% | Mar 2024 |
|
| Two Sigma Advisers | 17k | $56k | 100% | Mar 2024 |
|
| Bank of America Corporation | 15k | $51k | 100% | Mar 2024 |
|
| Pathway Financial Advisors | 14k | $47k | 100% | Mar 2024 |
|
| Two Sigma Securities | 13k | $43k | 100% | Mar 2024 |
|
| Geode Capital Management | 11k | $37k | 0% | Mar 2024 |
|
| Morgan Stanley | 10k | $34k | -1% | Mar 2024 |
|
| UBS Group | 9.0k | $30k | 100% | Mar 2024 |
|
| Atlantic Trust | 6.0k | $20k | 100% | Mar 2024 |
|
| Simplex Trading | 2.6k | $8.0k | 488% | Mar 2024 |
|
| Cutler | 1.3k | $3.9k | 100% | Mar 2024 |
|
| TSFG | 400.00 | $1.0k | 0% | Mar 2024 |
|
Who sold out of Lava Therapeutics Nv?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tang Capital Management | Dec 2023 | 841k | $1.3M |
| Tower Research Capital | Sep 2023 | 12k | $18k |